AcquisitionOther

AMGEN INC acquired Horizon Therapeutics plc

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

AMGEN INC -> Horizon Therapeutics plc · $116.50

We have strong momentum in our core business and the addition of Horizon will further position Amgen as a leader across a broader range of diseases. The compelling strategic and financial rationale for the acquisition includes: Alignment with Amgens core

Open source record (SEC) ↗